From the Rwanda Biomedical Center, Kigali, Rwanda.
Centers for Disease Control and Prevention-Rwanda, Kigali, Rwanda.
Pediatr Infect Dis J. 2019 Feb;38(2):149-151. doi: 10.1097/INF.0000000000002101.
Rwanda has made significant progress in expanding pediatric antiretroviral treatment coverage. This was a nationwide, cross-sectional study of pediatric HIV suppression rates. Of 292 children on antiretroviral treatment ≥12 months, 68.8% achieved viral suppression < 40 copies/ml, respectively. Rwanda achieved good pediatric viral suppression rates, comparable to those from other resource-limited settings, yet more efforts are needed to achieve the UNAIDS 90-90-90 target.
卢旺达在扩大儿科抗逆转录病毒治疗覆盖范围方面取得了重大进展。这是一项全国性的、横断面的儿科 HIV 抑制率研究。在 292 名接受抗逆转录病毒治疗≥12 个月的儿童中，分别有 68.8%达到了<40 拷贝/ml 的病毒抑制水平。卢旺达实现了良好的儿科病毒抑制率，与其他资源有限的地区相当，但仍需进一步努力，以实现联合国艾滋病规划署 90-90-90 的目标。
